Mistake 1: expecting injection-level results Setting expectations based on injectable semaglutide trial data and then being disappointed with drop results is extremely common
While occasionally harmless, persistent sulfur burps can indicate underlying digestive conditions that require professional attention
Compounded medications are not FDA-approved and are only used when determined appropriate by the treating provider.
Semaglutide, for example, has FDA-approved cardiovascular benefits for certain patients, while tirzepatide is also approved to treat obstructive sleep apnea in adults with obesity
On the other hand, Ozempic is just as pricey as Wegovy, but it's much more likely that insurance will cover it
Early appetite changes are common, while fat loss often follows as doses increase